Transparency Market Research Report Added "HIV Market" to its database.

Albany, NY -- (SBWire) -- 03/12/2015 --Human immuno deficiency virus better known as HIV/AIDS is one of the most catastrophic diseases/threats to the human race and health throughout the world. HIV causes AIDS. HIV was discovered in 1981, and since its existence dates back to more than 30 years, a number of changes have evolved in the market to improve the quality of life of the HIV patients. Substantial medical treatments, advancements in the medicine field, and new drug therapies have charmed the pharmaceutical industry tremendously.

Today, HIV is not considered to be a death sentence anymore. In fact, at present, the HIV market is deemed to mature, expand, and evaluate new drugs and therapies, along with numerous tested and tried treatment options to prove the effectiveness of minimizing this disease and increasing patient's life expectancy in the best manner possible.

Early buyers will receive 10% customization on reports:
http://www.transparencymarketresearch.com/hiv-market.html

Different Types of HIV Drugs

With the advent of new technologies in the field of medicine, several different types of human immunodeficiency virus (HIV) medications have been introduced on the market to treat individuals diagnosed with HIV virus. These drugs are mainly obtained in the form of reverse transcriptase inhibitors, protease inhibitors, and fusion inhibitors.

For reverse transcriptase inhibitors

These types of inhibitors are available in many forms. For instance, nukes are nucleoside or nucleotide reverse transcriptase inhibitors (NSTIs and NRTIs) that interfere with the reverse transcriptase enzyme to replicate. Similarly, there are non-nukes or non-nucleoside reverse transcriptase inhibitors (NNRTIs) as well.
Another group of HIV drugs which is known as integrase inhibitors act as a preventing drug to stop HIV to enter and form bonding with cells. It helps to prevent it from colonizing the cells and increasing the patient's viral load.

Moreover, the anti-retroviral therapy for HIV has tremendously oppressed the infection rates of HIV patients across the globe. In this therapy, a doctor typically prescribes drugs from two different drug classes to target the HIV virus from multiple angles.

Such a medication regimen is based on doctor's thorough evaluations, discussions, and medical tests, describing the exact nature of the treatment(s) of the affected patients.

Challenges in the HIV Market

Even with the presence of more effective and cost-effective drug therapies for HIV, HIV drug makers face handful of difficult competition and different challenges in this market. There are several newer drugs and therapies being introduced in the market to treat HIV and they continue to earn their total income from the European, as well as the U.S. markets. But, there will be a point of time, when several leaders will begin to lose their market protection by the year 2017.

Furthermore, the highest number of HIV-infected people is witnessed in poor countries. There is a majority of the HIV infected population living in sub-Saharan Africa region. Hence, worldwide pharmaceutical companies are ensuring to lower their costs in this region so that they can introduce their products to generic competition.

The generic types of HIV drugs include didanosine, zidovudine, stavudine, and lamivudine – all of which represents 46 percent of the global HIV market.

Global Market Share and Geographic Areas Covered

The global market for HIV therapeutics and diagnostics is expected to grow to $18.2 billion in 2013, and reach a value of $19.6 billion in 2017, along with a compound annual growth rate (CAGR) of 1.5% in the given forecast period. Considering the countries covered in the global study of HIV market, places such as, the US, Germany, France, Spain, Italy, the UK, Japan, and Canada are majorly dealing with HIV patients in large numbers.

More Reports on Pharmaceutical Market :
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

Enquiry Before Buying :
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=113

About Transparency Market Research
TMR's analysts and consultants are distinguished experts in their respective domains. The company is based on an employee-centric model and hires the best, brightest, and most passionate people in the industry. This unparalleled expertise helps TMR uncover latest market intelligence data that's distinct from the competition.

TMR is also a client-centric organization that endeavors to add value to the client's business by delivering the most insightful research. TMR understands that every client has unique product/service offerings, statement, and criteria. Customized solutions from TMR are centered on the client's problem statement. On the other hand, our syndicated research reports provide a packaged solution to keep enterprises abreast of the next major change in their industry.

Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: 518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Browse Market Research Blog:
http://researchreportsindustry.wordpress.com/